STRIDES PHARMA BENGALURU FACILITY
Away From Bihar This Chhath Puja? Check These Ghats in Delhi, Mumbai and Bengaluru
Thousands of families from Bihar, Jharkhand and eastern Uttar Pradesh celebrate Chhath Puja in cities far from their hometowns. From Yamuna-side ghats and neighbourhood ponds in Delhi to Juhu Beach in Mumbai and community-organised celebrations in Bengaluru, here are some places where devotees can observe Chhath Puja in 2026, along with practical details to check before visiting.
Workout after work: India Inc flexes its fitness muscle
Employers in India are enhancing workplace fitness programs to promote well-being and active lifestyles among employees. Companies like Procter & Gamble and InMobi now offer gym facilities and wellness initiatives. The demand for fitness programs is rising among mid-sized businesses and startups, providing greater access to wellness resources.
E20 debate widens: Karnataka to reveal probe findings on Monday; MoS Suresh Gopi backs OMCs
Karnataka authorities are set to reveal more information regarding the alleged excessive ethanol blending in petrol. Chief Minister DK Shivakumar stated that the government has received numerous complaints from motorists concerning vehicle performance issues. Inspection teams collected petrol samples from various retail fuel outlets and ethanol blending facilities across the state. Additionally, Kerala has ordered laboratory tests on petrol samples amid this controversy.
More than family business: Drugmakers make costly, long-term strategic shifts as next generation steps into bigger roles
India's family-run pharmaceutical companies are entering a new phase as the next generation takes on larger leadership roles and steers businesses towards complex generics, peptides, biologics, contract manufacturing and advanced therapeutics. Laurus Labs, Granules India, Bharat Biotech, Sun Pharma and Torrent Pharma are investing in capabilities that require greater scientific expertise, significant capital and longer gestation periods. The key question is whether the successors can turn these long-term bets into sustainable growth and create lasting value for investors.
Bayer to invest Rs 200 crore in Karnataka R&D facility, create 220 jobs
Bayer Science and Innovation has signed an MoU to invest Rs 200 crore in Karnataka for an R&D facility. This investment will be made over the next seven years and aims to create 220 jobs. The groundbreaking ceremony is scheduled before the Global Investors Meet planned for April next year. Bayer already has facilities in Bengaluru.
HSBC India arm leases 1.2 lakh sq ft office space in Bengaluru
HSBC's India division has secured a long-term sub-lease for more than 120,000 square feet of office space. This transaction is located in the commercial tower Ecospace Campus 1C on Outer Ring Road, Bengaluru. The lease includes a financial commitment of approximately Rs 191.84 crore over an initial five years. Following the lease terms, there is an option for a five-year extension at the same rate.
- Go To Page 1
Premji Invest pumps $35 million into Hical Technologies to expand aerospace, defence manufacturing
Premji Invest has invested $35 million in Bengaluru-based Hical Technologies, marking the aerospace and defence components maker’s first institutional funding in nearly four decades. The company, valued at $300 million-$400 million according to industry sources, will use the capital to expand manufacturing capacity, engineering capabilities and R&D across South India.
Bayer signs MoU with Karnataka government for ₹200 crore manufactuing facility near Bengaluru
Bayer Science and Innovation signed a Memorandum of Understanding with the Karnataka government to establish a manufacturing facility. The investment is worth ₹200 crore and is expected to create around 220 jobs. The agreement was signed in the presence of Large and Medium Industries Minister M. B. Patil. Bayer intends to break ground before the Global Investor's Meet scheduled for April 2027.
Scripbox shareholders approve conversion into public company ahead of IPO
At an extraordinary general meeting on October 19, shareholders approved the change of the Accel-backed startup's name from Scripbox Wealth Managers Private Limited to Scripbox Wealth Managers Limited, along with amendments to its constitutional documents, according to regulatory filings reviewed by ET.
FDA flags persistent data-integrity lapses, insanitary conditions at Indian drug facilities
The US FDA continues to identify serious data integrity issues in Indian pharmaceutical manufacturing facilities. During inspections, inspectors found discarded documents related to key manufacturing processes, highlighting compliance concerns. To ensure safe medicines, drugmakers are urged to scrutinize their supply chains and monitor suppliers effectively. Additionally, human errors contributed significantly to production incidents, affecting operations and batch release timelines.
Stocks in news: Bharti Airtel, LIC, Titan, ONGC, Bharti Hexacom, Glenmark Pharma and Astral
Indian equity markets continued their upward trend, highlighted by the Nifty 50 gaining 576 points. Bharti Airtel, LIC, and Titan Company reported strong profit increases for the September quarter. ONGC also posted a substantial rise in consolidated profit compared to last year. In contrast, Glenmark Pharmaceuticals faced a significant decline in net profit this quarter. Overall, corporate developments are influencing investor sentiment as markets react to earnings reports.
Railway platform ticket sales suspended at six stations across Delhi and Ghaziabad; check the full list
Railway news: Northern Railway is implementing crowd-management measures at major railway stations in Delhi-NCR during the festive season. Platform ticket sales have been suspended at six key railway stations until November 14 to manage crowds. Special trains are being operated to accommodate the anticipated travel rush for Diwali and Chhath festivals. Enhanced passenger facilities, including holding areas, aim to improve the travel experience during this busy period.
Pills are paying off! Pharma stocks lead 2026 rally with up to 112% return
In 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic demand alongside enhanced profitability from new product launches. Notable players like Laurus Labs and Gland Pharma have recorded remarkable returns, topping 100%. Amid challenges faced by other sectors, the pharmaceutical field demonstrates resilience. Analysts are optimistic but advise exercising caution regarding potential market volatility and the durability of this sector's performance.
Bengaluru techies' lifestyle spending: Couple spends Rs 1.73 lakh monthly, Rs 75,000 for travel and Rs 60,000 rent
A Bengaluru couple reveals their eye-popping monthly spending habits, allocating Rs 75,000 for travel and Rs 60,000 for rent. Shubhi Khandelwal shares insights on their budgeting strategies, emphasizing easy tracking methods. Meanwhile, another local couple's relocation to Goa highlights the financial considerations of choosing a lifestyle change. Explore how these tech professionals manage expenses while saving and investing.
altM raises $10.3 million to scale production of specialty chemicals from agricultural waste
Founded in 2022 by former Tesla manufacturing executives Apoorv Garg and Yugal Raj Jain, altM develops specialty chemicals and biomaterials by converting agricultural residue such as sugarcane bagasse and rice straw into industrial inputs that can replace conventional fossil-derived materials.
Stocks in news: BSE, Lenskart, Nykaa, Bharti Airtel, LIC, Aurobindo Pharma and Nalco
Indian equity markets have enjoyed a remarkable stretch, registering gains for five consecutive sessions. The Nifty 50 index showed impressive growth, sparking optimism for a breakout beyond 24,000. Companies like Lenskart, Aurobindo Pharma, and BSE are in the spotlight as they report positive earnings. Experts advise keeping an eye on the support levels as the bullish trend persists.
Apollo Hospitals plans to add 5,800 beds over next five years, Gurugram facility to open in Q3 FY27
Apollo Hospitals is set to enhance its capacity by adding around 5,800 beds within the next five years. Their Gurugram facility, featuring approximately 470 beds, is expected to open by the third quarter of FY27.
Unilever announces €35 million investment for R&D expansion in India’s Mumbai and Bengaluru hubs
Unilever announced a plan to invest an additional €35 million in its Indian research and development operations. The investment aims to enhance product innovation and biotechnology capabilities at its Mumbai and Bengaluru centers. Unilever has already invested €20 million over the past five years towards developing various research facilities in India.
Indian airlines seek to boost domestic MRO capabilities as aircraft fleets expand
Indian airlines are focusing on building in-house capabilities for maintenance and repair as the aircraft fleet grows. Air India plans to establish an MRO facility in Bengaluru by 2027, while IndiGo emphasizes the need for self-reliance. Akasa Air's maintenance facility at Noida airport is expected to be operational by 2028. The commercial aircraft fleet in India, currently around 800, is predicted to double in coming years as air traffic increases.
Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%
Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
Astrobase, Bayer to invest Rs 700 crore in Karnataka, creating nearly 1,500 jobs
Astrobase and Bayer have announced a combined investment of Rs 700 crore in Karnataka. Astrobase will invest Rs 500 crore to set up a manufacturing facility for rocket engines. This project aims to create approximately 1,250 jobs in the region. Bayer plans to invest Rs 200 crore to establish a Global Capability Centre, generating around 220 jobs. Both investments reflect a growing interest in expanding industrial capabilities in Karnataka.
15+ features of India's first Bullet Train: Not just 280 kmph speed, check its interiors, passenger facilities and advanced technology
India's first indigenous bullet train, B28, is designed to run at an operational speed of 249 kmph and a testing speed of 280 kmph. With eight coaches and a passenger capacity of around 557, it will feature Wi-Fi-based infotainment, multilingual information screens, ergonomic seating and modern safety systems. Trial runs on the Mumbai-Ahmedabad corridor are targeted for May-June 2027.
Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 crore
Mold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Strong pharma and FMCG packaging volumes supported performance, while new product launches and expansion plans strengthened its growth outlook.
L&T bags orders for residential and commercial projects in 3 cities
Larsen & Toubro has announced securing multiple construction orders from a significant client in various cities. Projects include high-rise residential towers in Mumbai and Bengaluru with varying basement and floor counts. Additionally, a premium commercial tower is set to be constructed in Hyderabad. The company is also continuing with add-on orders for its ongoing projects. These undertakings highlight L&T's commitment to enhancing infrastructure in major urban areas.
India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugs
Over the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth rate reached 12% year-on-year in the September quarter, showing a positive trend in the industry. Larger pharmaceutical companies have benefited from the shutdown of many non-compliant smaller units. Budgets were also boosted by a reduction in GST on medicines.
PM approves Southern bullet train corridor linking Bengaluru, Hyderabad, Amaravati and Chennai: Vaishnaw
Prime Minister Narendra Modi has approved the Southern Bullet Train Corridor which will connect Bengaluru, Hyderabad, Amaravati, and Chennai. This high-speed rail project aims to reduce travel time significantly between these economic hubs. The Bengaluru-Chennai journey will take just 73 minutes, while Bengaluru-Hyderabad will take about two hours and 10 minutes.
India to export Vande Bharat trains in 3-4 years: Ashwini Vaishnaw
India will commence the export of Vande Bharat trains in three to four years. The Bengaluru-Mumbai Vande Bharat Sleeper train has been recently launched to enhance overnight travel comfort. It features advanced design improvements aimed at passenger convenience and aims to reduce travel time significantly. Fares for the sleeper service are competitive compared to international train services.
Railway Minister Ashwini Vaishnaw flags off Bengaluru-Mumbai Vande Bharat Sleeper: Check route, stoppages and timings
Railway Minister Ashwini Vaishnaw inaugurated the Bengaluru-Mumbai Vande Bharat Sleeper Express on November 1. The train service will operate six days a week, excluding Mondays, connecting major stations along its route. Passengers will benefit from an overnight travel option between Bengaluru and Mumbai. This launch follows the introduction of a similar service between Varanasi and New Delhi.
Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: Report
Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision followed the discovery of failures in the company's quality management system. A joint inspection cited lapses that affected drug safety and quality, leading to a recall of several eye-drop brands. Significant adverse cases have raised concerns regarding product contamination, prompting further investigation.
Load More
